Search

for
Search:

Sort by

Research

990-1000 / 1000+ results

Dysregulation of Leukemia Inhibitory Factor (LIF) Signaling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity

research Dysregulation of Leukaemia Inhibitory Factor (LIF) Signalling Pathway by Supraphysiological Dose of Testosterone in Female Sprague Dawley Rats During Development of Endometrial Receptivity

January 2025 in “Biomedicines”

High testosterone levels can harm fertility by disrupting the LIF signaling pathway in the uterus.

research LUPUS AROUND THE WORLD Clinical and immunological manifestations in 151 SLE patients living in Dubai

January 2008

SLE symptoms in Dubai are similar to those in other Arab and Western countries.

research A Hero Revealed: Targeting the AHR for treatment of inflammatory skin diseases

September 2025 in “Radboud University Press eBooks”

AHR ligands could treat inflammatory skin diseases.

research What to Look for in Red Light Therapy: A Product Guide Backed by Science

March 2026 in “Cureus”

Choose FDA-cleared red light therapy devices and follow guidelines for safe use.

Overexpression of Aldo-Keto Reductase 1C3 in LNCaP Cells Diverts Androgen Metabolism Towards Testosterone Resulting in Resistance to the 5α-Reductase Inhibitor Finasteride

research Overexpression of aldo-keto reductase 1C3 (AKR1C3) in LNCaP cells diverts androgen metabolism towards testosterone resulting in resistance to the 5α-reductase inhibitor finasteride

45 citations , January 2012 in “The Journal of Steroid Biochemistry and Molecular Biology”

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: Three-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies

research Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies

March 2026 in “American Journal of Clinical Dermatology”

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Why Care About Linear Hair Growth Rates? A Study Using In Vivo Imaging and Computer-Assisted Image Analysis After Manual Processing in Unaffected Male Controls and Men with Male Pattern Hair Loss

research Why care about Linear Hair Growth Rates (LHGR)? A study using in vivo imaging and computer assisted image analysis after manual processing (CAIAMP) in unaffected male controls and men with male pattern hair loss (MPHL)

7 citations , September 2014 in “European Journal of Dermatology”

Thicker hair grows faster; hair loss patients have slower growth.

research Different effects of phospholipase Dζ2 and non‐specific phospholipase C4 on lipid remodeling and root hair growth in Arabidopsis response to phosphate deficiency

65 citations , February 2018 in “The Plant Journal”

PLDζ2 and NPC4 have different roles in lipid changes and root hair growth in Arabidopsis under low phosphate, with PLDζ2 reducing root hair growth and NPC4 promoting it.

research Efficient Gene Editing for Heart Disease via ELIP-Based CRISPR Delivery System

6 citations , February 2024 in “Pharmaceutics”

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.

research Low-dose oral minoxidil for androgenetic alopecia is not associated with significant changes in alcohol consumption: a retrospective study of 21,971 patients

January 2025 in “Skin Appendage Disorders”

Low-dose oral minoxidil does not significantly change alcohol consumption.

← Previous page